KBC Company (KEYBISI) income statement
Operating revenue through to net profit and earnings per share
- Ticker
- KEYBISI
- Industry
- Pharmaceuticals
- Market
- Iran Fara Bourse
Latest periods
| Item | To 1405/06/31 | To 1404/06/31 | To 1403/06/31 | To 1402/06/31 | To 1401/06/31 | To 1400/06/31 |
|---|---|---|---|---|---|---|
| Operating revenue | 12,567,357 | 5,722,156 | 3,616,098 | 3,615,903 | 3,387,322 | 3,704,735 |
| Cost of operating revenue | -8,683,250 | -5,215,551 | -3,151,141 | -2,806,896 | -2,851,534 | -2,895,237 |
| Gross profit (loss) | 3,884,107 | 506,605 | 464,957 | 809,007 | 535,788 | 809,498 |
| Selling, general and administrative expenses | -1,006,609 | -524,138 | -272,909 | -268,778 | -139,886 | -93,356 |
| Other expenses | -157,342 | -632,322 | -71,165 | -18,911 | -62,531 | -96,721 |
| Operating profit (loss) | 2,720,156 | -649,855 | 179,900 | 525,839 | 334,593 | 622,527 |
| Finance costs | -3,198,023 | -1,435,299 | -1,173,322 | -687,591 | -252,589 | -205,897 |
| Other non-operating income and expenses | 586,677 | 1,265,350 | 9,209 | 1,076,868 | 296,399 | 61,278 |
| Profit (loss) from continuing operations before tax | 108,810 | -819,804 | -984,213 | 915,116 | 378,403 | 477,908 |
| Net profit (loss) from continuing operations | 108,810 | -819,804 | -984,213 | 802,385 | 356,336 | 380,996 |
| Net profit (loss) | 108,810 | -819,804 | -984,213 | 802,385 | 356,336 | 380,996 |
| Basic earnings (loss) per share | 63 rials | -1,108 rials | 0 rials | 0 rials | 0 rials | 1,290 rials |
| Net earnings (loss) per share, rials | 63 rials | -1,107 rials | -1,330 rials | 1,638 rials | 1,229 rials | 1,314 rials |
| Capital | 1,740,000 | 740,000 | 740,000 | 490,000 | 290,000 | 290,000 |
Reporting periods
59 periods are on file for this report, from the period ending 1391/12/30 to the period ending 1405/06/31.